Low–Molecular Weight Heparin Beyond 12 Months in Patients With Cancer-Associated Thrombosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis
Br. J. Cancer 2022 Oct 14;[EPub Ahead of Print], S Lopez-Ruz, M Barca-Hernando, S Marin-Romero, T Elias-Hernandez, R Otero-Candelera, L Jara-PalomaresFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.